Iqra Mumal, MSc,  —

Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.

Articles by Iqra Mumal

Signant, Propeller Health to Connect Systems on Inhaler Use Data

Signant Health and Propeller Health are connecting their systems to help improve asthma and chronic obstructive pulmonary disease (COPD) patients’ adherence to inhaled medication and symptom control. Signant said it will connect its TrialMax electronic clinical outcome assessment (eCOA) platform to Propeller’s digital health platform for…

Triple Combo Therapy Breztri Aerosphere Approved in Japan for COPD

AstraZeneca’s triple combination therapy Breztri Aerosphere, formerly known as PT010, has been approved in Japan for the treatment of symptoms of chronic obstructive pulmonary disease (COPD). This makes Japan the first country to grant regulatory approval for Breztri Aerosphere. Breztri Aerosphere, which is composed of budesonide, glycopyrronium…

Physicians Are First in U.S. to Perform Robotic-assisted Lung Surgery

Physicians at Illinois’ Northwestern Memorial Hospital are the first in the United States to successfully perform a robotic-assisted lung volume reduction surgery (LVRS) to extract diseased tissue from the lungs of patients with severe emphysema, a progressive form of chronic obstructive pulmonary disease (COPD). The first procedure was done in late…

COPD Foundation Launches App to Help Providers, Patients

The COPD Foundation has launched an app called the COPD Pocket Consultant Guide (PCG), designed to help healthcare providers in the treatment and management of patients with chronic obstructive pulmonary disease (COPD). Links to download the app, either for Android or iOS, can be found here. The main features…

Testosterone Replacement Therapy Can Slow Men’s COPD, Study Finds

Testosterone replacement therapy can help slow the progression of chronic obstructive pulmonary disease (COPD) in men, a new study shows. Men with COPD tend to experience shortness of breath, leading physicians to prescribe them long-term steroid-based medications. While these medications help treat pulmonary symptoms, they are also associated with…